EMA Begins Setting Up New Bodies To Tackle Drug Shortages
Workshop To Be Held To Explain Agency's Expanded Role
Executive Summary
A new EU regulation has come into effect, giving the European Medicines Agency wider powers to monitor, prevent and manage shortages of medicines and medical devices in public health emergencies. A number of steering groups and other bodies and networks are being set up to put the new systems into action.
You may also be interested in...
New EU Body To Take The Strain As Talks On Pharma Overhaul Near
A new EU subcommittee is to be set up to advise on matters relating to pharmaceuticals, the European Medicines Agency and public health.
‘Main Issue’ Facing Generics Security Of Supply Is Price, Politico Panel Hears
Panelists discussed the issues jeopardizing generics security of supply, the potential impact of pricing changes and international best practice at a recent Politico event.
New EU Rules Imminent On Joint Procurement Of Vaccines & Drugs In Health Crises
EU legislation just approved by legislators will require the European Commission to provide information on prices, manufacturers, delivery time frames and joint procurement processes for vaccines and medicines used in tackling future health crises such as pandemics.